HF
MRVI icon

HRT Financial’s Maravai LifeSciences MRVI Stock Holding History

HRT Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.67M Buy
1,068,754
+992,471
+1,301% +$4.28M 0.01% 980
2026
Q1 		$215K Sell
76,283
-291,628
-79% -$989K ﹤0.01% 3153
2025
Q4 		$1.2M Buy
+367,911
New +$1.24M ﹤0.01% 1619
2025
Q2 		– Sell
-33,116
Closed -$73K – 3228
2025
Q1 		$73K Sell
33,116
-120,559
-78% -$476K ﹤0.01% 2199
2024
Q4 		$837K Buy
+153,675
New +$989K ﹤0.01% 1162
2024
Q2 		– Sell
-397,947
Closed -$3.45M – 2769
2024
Q1 		$3.45M Buy
397,947
+285,561
+254% +$1.93M 0.02% 375
2023
Q4 		$736K Buy
+112,386
New +$726K 0.01% 1148
2023
Q3 		– Sell
-96,365
Closed -$1.2M – 2835
2023
Q2 		$1.2M Buy
96,365
+78,619
+443% +$1.06M 0.01% 840
2023
Q1 		$248K Buy
+17,746
New +$255K ﹤0.01% 1827
2022
Q3 		– Sell
-9,176
Closed -$260K – 3248
2022
Q2 		$260K Sell
9,176
-33,371
-78% -$1.06M ﹤0.01% 2113
2022
Q1 		$1.5M Buy
+42,547
New +$1.43M 0.01% 781
2021
Q1 		– Sell
-305,395
Closed -$8.57M – 2981
2020
Q4 		$8.57M Buy
+305,395
New +$8.5M 0.17% 95

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

HRT Financial's MRVI Position: Q2 2026 in Review

HRT Financial increased its Maravai LifeSciences (MRVI) stake by 1,301% in Q2 2026, buying an estimated $4.28M and bringing the position to 1,068,754 shares worth $6.67M. The position accounts for 0.01% of the portfolio, ranked #980.

HRT Financial first reported a position in MRVI in Q4 2020 and has held it in 12 quarters since. The position peaked at $8.57M in Q4 2020. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • HRT Financial held 1,068,754 shares of Maravai LifeSciences worth $6.67M as of Q2 2026.
  • HRT Financial bought 992,471 Maravai LifeSciences shares in Q2 2026, an estimated $4.28M.
  • Maravai LifeSciences made up 0.01% of HRT Financial's portfolio in Q2 2026, its #980 holding.
  • HRT Financial first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 12 quarters since.
  • HRT Financial's Maravai LifeSciences position peaked at $8.57M in Q4 2020.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.